The article of Robert F. Benson et al. entitled "Evaluation of the Binax and Biotest urinary antigen kits for detection of Legionnaires' disease due to multiple serogroups and species of Legionella" (1) states the following in the abstract: "Eighteen were positive with the Binax kit, and 13 were positive with the Biotest." This statement is misleading since data in both the article and Table 1 show that of 45 urine samples previously positive by the enzyme-linked immunosorbent assay of Tang and Toma (3), 45 were tested with the Binax enzyme immunoassay (EIA), and of these, 10 were positive and 35 were negative. Forty-two of the 45 were tested with the Biotest EIA; of these, 13 were positive and 29 were negative (3 were not tested). Obviously, there was a retest with the Binax radioimmunoassay: 26 of the 45 samples were retested. Of these, 13 were positive and 13 were negative (19 were not tested).
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We appreciate Dr. Horn's comments and offer the following response. In the abstract of our article (1), the number of samples listed as positive for the Binax kit was the total for both the EIA and RIA kits. This point was not stated directly in the abstract, but, as Dr. Horn acknowledges, this is described in detail in the text and in Table 1 of the article. We also stated that only the results of the Binax EIA were used for comparison to the Biotest EIA. In regards to the literature cited, we were not aware of the results presented at the EWGLI meeting in 1997 but only of the results presented in the article by Harrison et al. (2) . We appreciate Dr. Horn's clarification of the results published by Dr. Harrison. Our results tend to support Dr. Horn's statement that the Biotest EIA is more sensitive than the Binax EIA in detecting 13 of 42 versus 10 of 45 urine samples. Dr. Horn states that the Biotest EIA has two cutoff values for positive results. This information is not stated in the product insert we received with the kit. If this is the case, the product insert should be changed to indicate that a lower cutoff can be used. Our observations of the positive samples compared to the negative samples is supported by Dr. Horn's statement. The purpose of our study was to show that both tests, while not as sensitive as the broadspectrum assay, are capable of detecting nonserogroup-1 Legionnaires' disease.
